- Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
-
Nakhjavani M, Hardingham JE, Palethorpe HM, Price TJ, Townsend A
- KMID: 2458857
- J Breast Cancer.
- 2019 Sep;22(3):341-361.
- doi: 10.4048/jbc.2019.22.e39
Breast cancer (BC) is still the most common cancer among women worldwide. Amongst the subtypes of BC, triple negative breast cancer (TNBC) is characterized by deficient expression of estrogen, progesterone,... -
- CITED
-
- Close
- SHARE
-
- Close
